Inovio Pharmaceuticals Raises $80.5 Million in Public Offering
PUBLIC · INONov 09, 2026
Amount Raised
$80.5 Million
Round Type
Post-IPO Equity
Plymouth MeetingBiotechnology
Investors
Piper Sandler & Co.Jefferies LLC
Description
Inovio Pharmaceuticals, Inc. completed a public offering of 58,747,235 shares of its common stock and pre-funded warrants, totaling approximately $80.5 million in net proceeds. The offering included an option for underwriters to purchase additional shares, which was fully exercised. The transaction is expected to close on or about November 9, 2026
Who to call at Inovio, and when
A new round usually means Inovio is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Inovio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Inovio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inovio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Inovio
Location
660 W. Germantown Pike
Plymouth Meeting, Pennsylvania, United States
About
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inovio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Plymouth MeetingBiotechnology